Header Logo

Connection

AMAN U BUZDAR to Drug Evaluation, Preclinical

Back to Details
This is a "connection" page, showing publications AMAN U BUZDAR has written about Drug Evaluation, Preclinical.
AMAN U BUZDAR
Connection Strength
0.072
Drug Evaluation, Preclinical
  1. Fulvestrant--a novel estrogen receptor antagonist for the treatment of advanced breast cancer. Drugs Today (Barc). 2008 Sep; 44(9):679-92.
    View in: PubMed
    Score: 0.072
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.